Back to results

Universidade Federal da Paraíba

Evolução da leucemia mielóide crônica frente à terapia com inibidores de tirosina cinase.

Abstract

dc:description.abstract

The Chronic Myeloid Leukemia (CML ) is a myeloproliferative disease by developing skilled clone of hematopoietic cells carrying Philadelfia chromoso me ( Ph ) , deriving the respective translocation between the long arms of chromosomes 9 and 22 , t( 9:22) (q34;11 ). As a result of this molecular translocatio n, there yielding a fusion BCR - ABL gene, which encodes an abnormal protein constitutively a ctive . The d evelopm ent of tyrosine kinase (ITK) BCR - ABL , princi pled for more than a decade ago , has revo lutionized the treatment of CML . The sources used for the development of scientific origin were working in the a reas of Oncology and Hematology . The information was tak en from bibliographic databases , searched from J anuary 2013 until February 2014 , investigated in the Ministry of Hea lth website of Medline/PubMed, Scielo, Scirus , and Science Direct and Ordinance Nº 1219 data, November 4 201 3/MS . The treatment of leukemia is focused on expanding the possibilities for healing and improving qu ality of life of these patients . The oral chemotherapy is a new tool for cancer treatment , and has been proven effective and is becoming more common be cause it is simple, economical, non - i nvasive and less toxic . Is also possible that the treatment is performed in the patient's home . Among the tr eatments available for leukemia , oral chemothera py is through preventive agents , as is the case of imatin ib (Glivec ® ), Dasatinib (Sprycel ® ) and Nilotinib (Tasigna ® ) that are used by chemotherapy patients with Chronic Myeloid Leukemia (LMC) . This study aims to review information about CML and treatment progress against ITK

Degree

thesis:*
Grantor dc:publisher
Universidade Federal da Paraíba
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Medeiros, Leanio Eudes dos Santos

Subjects

dc:subject × 3

Rights

Language dc:language.iso
pt

Identifiers

dc:identifier.*
Repository record dc:identifier.uri
https://repositorio.ufpb.br/jspui/handle/123456789/607
OAI identifier oai:identifier
oai:repositorio.ufpb.br:123456789/607

Chain of custody

source
Harvested from
Brazil UFPB
Base URL
repositorio.ufpb.br/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Medeiros, Leanio Eudes dos Santos. Evolução da leucemia mielóide crônica frente à terapia com inibidores de tirosina cinase.. Universidade Federal da Paraíba, 2014. https://repositorio.ufpb.br/jspui/handle/123456789/607